PATENT CLAIM ANALYSIS

Application Number: 16184432
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-02
Patent Classification: ["536", "024500"]

Abstract:
The present invention relates to methods and pharmaceutical compositions for the treatment of filovirus infections. In particular, the present invention relates to a method of treating filovirus infection in a subject in need thereof comprising administering the subject with a therapeutically effective amount of at least one oligonucleotide comprising the sequence as set forth in SEQ ID NO:1 to SEQ ID NO:15.

Claim (Index 5):
The method of  claim 1  wherein said at least one oligonucleotide is conjugated to nanoparticles.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 98.0
- Lexical Diversity: 1.44444
- Patent Class: 536.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15557164', '11433840', '13957261', '10066506', '12853180']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5745235562338921
- 35 USC 102 Novelty (BERT): 0.4993722796639508
- Combined Prediction Score: 0.5670084285768979
- Mean Citation Score: 196.667136
- Max Citation Score: 264.1364
- Similarity Product: 218.41176136333945

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test